Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3068% below fair value
$4.03+0.02 (+0.50%)
Close on Nov 13, 2026Market cap $196.17MP/E –Yield –
Nu Skin Enterprises price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Nu Skin Enterprises's price to sales ratio was 0.1× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.1× to 0.9×, with a median of 0.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.1× | −0.2 |
| 2025 | Dec 31, 2025 | 0.3× | +0.1 |
| 2024 | Dec 31, 2024 | 0.2× | −0.3 |
| 2023 | Dec 29, 2023 | 0.5× | −0.4 |
| 2022 | Dec 30, 2022 | 0.9× | −0.0 |
| 2021 | Dec 31, 2021 | 0.9× | −0.3 |
| 2020 | Dec 31, 2020 | 1.2× | +0.3 |
| 2019 | Dec 31, 2019 | 0.9× | −0.4 |
| 2018 | Dec 31, 2018 | 1.3× | −0.4 |
| 2017 | Dec 29, 2017 | 1.7× | +0.5 |
| 2016 | Dec 30, 2016 | 1.2× | +0.4 |
| 2015 | Jan 30, 2015 | 0.8× | −0.1 |
| 2014 | Dec 31, 2014 | 0.8× | – |
See a number that looks wrong?